Sangamo BioSciences ZFP Therapeutic Program In HIV/AIDS Featured At Three Major Scientific Conferences In October 2014

By: via Benzinga
Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced that Company scientists and clinicians, as well as academic collaborators, were ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.